At the ACBS World Conference 2025, PsyTech VR took center stage to demonstrate the transformative potential of VR exposure therapy in treating a range of mental health conditions, including anxiety, phobias, OCD, PTSD, addictions, and anger management. Represented by advisory board members Dr. Gwilym Roddick and Dr. Melanie Smith, the company engaged with clinicians worldwide, showcasing how VR technology can bring therapy to life in innovative, accessible, and effective ways.
PsyTech VR's booth at the conference offered attendees a hands-on experience with the platform, allowing them to explore how mental health professionals utilize VR scenes for exposure therapy. The emphasis was on clinical applications, demonstrating the platform's ability to create structured, immersive, and personalized environments for therapy. Developed with science-backed usage protocols, PsyTech VR aims to simplify the integration of VR into clinical practices, making it a clinically sound option for mental health professionals.
The response from conference attendees was overwhelmingly positive, with many expressing enthusiasm for incorporating VR technology into their cognitive behavioral therapy (CBT) practices. The potential of VR to enhance the effectiveness and engagement of therapy, while also expanding access to evidence-based care, was a key takeaway from the event. Dr. Roddick highlighted the inspiring eagerness of clinicians to adopt this cutting-edge technology, noting its power to take exposure therapy beyond traditional methods into new realms of possibility.
This demonstration at the ACBS World Conference 2025 underscores the growing recognition of VR's role in mental health treatment. By offering a glimpse into the future of therapy, PsyTech VR is paving the way for innovations that could significantly impact the mental health industry and the lives of individuals seeking treatment for various conditions.
